CD274 and colorectal carcinoma: Given that the endogenous expression level of PD-L1 in CRC is a critical factor, screening for stabilizing agents or regulating PD-L1 protein abundance via the ubiquitin-proteasome system may serve as an alternative therapeutic approach for CRC.